Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment
{{output}}
Background: Polycythemia vera (PV) is a myeloproliferative neoplasm. Ropeginterferon alfa-2b is a new-generation polyethylene glycol-conjugated proline-interferon. It is approved for the treatment of PV at a starting dose of 100 ... ...
